Activation of A3 receptors by endogenous adenosine inhibits synaptic transmission during hypoxia in rat cortical neurons

Restorative Neurology and Neuroscience

Volumn 21, Issue 1-2, 2003, Pages 55-63

  Hentschel, S ^a   Lewerenz, A ^a   Nieber, Karen ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

A3 receptor; Adenosine; Cortex; Hypoxia; Pyramidal cells; Synaptic potentials

Indexed keywords

3 PROPYL 6 ETHYL 5 [(ETHYLTHIO)CARBONYL] 2 PHENYL 4 PROPYL 3 PYRIDINE CARBOXYLATE; 6 ETHYL 4 PROPYL 2 PHENYL 3 PYRIDINECARBOXYLIC ACID 5 THIOCARBOXYLIC ACID 5 ETHYL 3 PROPYL ESTER; 6 N (3 IODOBENZYL)ADENOSINE 5' N METHYLCARBOXAMIDE; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; 9 (2 HYDROXY 3 NONYL)ADENINE; 9 CHLORO 2 (2 FURYL) 5 PHENYLACETYLAMINO 1,2,4 TRIAZOLO[1,5 C]QUINAZOLINE; ADENOSINE; ADENOSINE DEAMINASE; CARBOXYLIC ACID DERIVATIVE; G PROTEIN COUPLED RECEPTOR; GUANOSINE 5' O (2 THIODIPHOSPHATE); NITROBENZYLTHIOGUANOSINE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BRAIN CELL; CINGULATE GYRUS; DRUG ANTAGONISM; DRUG EFFECT; ELECTROSTIMULATION; HYPOXIA; NONHUMAN; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RAT; RECEPTOR BLOCKING; SYNAPTIC INHIBITION; SYNAPTIC POTENTIAL; SYNAPTIC TRANSMISSION;

ADENINE; ADENOSINE; ANIMALS; CELL HYPOXIA; CEREBRAL CORTEX; DRUG INTERACTIONS; ELECTRIC STIMULATION; ENZYME INHIBITORS; EXCITATORY POSTSYNAPTIC POTENTIALS; GUANOSINE; GUANOSINE DIPHOSPHATE; MALE; NEUROTRANSMITTER UPTAKE INHIBITORS; PYRAMIDAL CELLS; RATS; RATS, WISTAR; RECEPTOR, ADENOSINE A3; RECEPTORS, PURINERGIC P1; SYNAPTIC TRANSMISSION; THIONUCLEOSIDES; THIONUCLEOTIDES; TIME FACTORS;

EID: 0038265892     PISSN: 09226028     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. M.P. Abbracchio, G. Fogliatto, A.M. Paoletti, G.E. Rovati and F. Cattabeni, Prolonged in vitro exposure of rat brain slices to adenosine analogues: selective desensitization of adenosine A1 but not A2 receptors, Eur. J. Pharmacol. 227 (1992), 317-324.
2. 3 receptors in rat brain, Molecular Pharmacology 48 (1995), 1038-1045.
3. A. Brand, Z. Vissiennon, D. Eschke and K. Nieber, Adenosine A(1) and A(3) receptors mediate inhibition of synaptic transmission in rat cortical neurons, Neuropharmacology 40 (2001), 85-95.
4. R.F. Bruns, J.H. Fergus, E.W. Badger, J.A. Bristol, L.A. Santay, J.D. Hartman, S.J. Hays and C.C. Huang, Binding of the A1 selective adenosine antagonist 8-cyclopentyl-1,3-dipropylxanthine to rat brain membranes, Naunyn-Schmiedebergs Arch. Pharm. 335 (1987), 59-63.
5. D.W. Choi, Cerebral hypoxia: some new approaches and unanswered questions, J. Neurosci. 10(8) (1990), 2493-2501.
6. B.W. Connors and M.J. Gutnick, Intrinsic firing patterns of diverse neocortical neurons, Trends Neurosci. 13 (1990), 99-104.
7. R.A. Cunha, E. Milusheva, E.S. Vizi, J.A. Ribeiro and A.M. Sebastian, Excitatory and inhibitory effects of A1 and A2A adenosine receptor activation on the electrically evoked [3H]acetylcholine release from different areas of the rat hippocampus, J. Neurochem. 63 (1994), 207-214.
8. R.A. Cunha, J.A. Ribeiro and A.M. Sebastiao, Purinergic modulation of the evoked release of [3H]acetylcholine from the hippocampus and cerebral cortex of the rat: role of the ectonucleotidases, Eur. J. Neurosci. 6 (1994), 33-42.
9. A. Deussen, Metabolic flux rates of adenosine in the heart, Naunyn Schmiedebergs Arch. Pharmacol. 362 (2000), 351-363.
10. C.D. Dora, S. Koch, A. Sanchez, G. Ruenes, S. Liu and R.P. Yezierski, Intraspinal injection of adenosine agonists protect against L-NAME induced neuronal loss in the rat, J. Neurotrauma 15 (1998), 473-483.
11. T.V. Dunwiddie and B.J. Hoffer, Adenine nucleotides and synaptic transmission in the in vitro rat hippocampus, Br. J. Pharmacol. 69(1) (1980), 59-68.
12. T.V. Dunwiddie and L. Diao, Extracellular adenosine concentrations in hippocampal brain slices and the tonic inhibitory modulation of evoked excitatory responses, J. Pharmacol. Exp. Ther. 8(2) (1994), 537-545.
13. T.V. Dunwiddie and S.A. Masino, The role and regulation of adenosine in the central nervous system, Annu. Rev. Neurosci. 24 (2001), 31-55.
14. D. Eschke, A. Brand, P. Scheibler, S. Hess, K. Eger, C. Allgaier and K. Nieber, Effect of an adenosine A(1) receptor agonist and a novel pyrimidoindole on membrane properties and neurotransmitter release in rat cortical and hippocampal neurons, Neurochem. Int. 38 (2001), 391-398.
15. J. Fastbom and B.B. Fredholm, Regional differences in the effect of guanine nucleotides on agonist and antagonist binding to adenosine A1 receptors in rat brain, as revealed by autoradiography, Neuroscience 34 (1990), 759-769.
16. J.C. Fowler, Purine release and inhibition of synaptic transmission during hypoxia and hypoglycemia in rat hippocampal slices, Neurosci. Lett. 157 (1993), 83-86.
17. B.B. Fredholm, A.P. IJzerman, K.A. Jacobson, K.N. Klotz and J. Linden, International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors, Pharmacol. Rev. 53(4) (2001), 527-552.
18. N. Fujiwara, H. Higashi, K. Shimoji and M. Yoshimura, Effects of hypoxia on rat hippocampal neurones in vitro, J. Physiol. 384 (1987), 131-151.
19. C. Gallo-Rodriguez, X.D. Xi, N. Melman, B.D. Siegman, L.H. Sanders, J. Orlina, Q. Pu, M.E. Olah, P.J.M. van Galen, G.L. Stiles and K.A. Jacobson, Structure-activity-relationships of N6-benzyladenosine-5'-uronamides as A3-selective adenosine agonists, J. Med. Chem. 37 (1994), 636-646.
20. S. Garcia de Arriba, H. Franke, M. Pissarek, K. Nieber and P. Illes, Neuroprotection by ATP-dependent potassium channels in rat neocortical brain slices during hypoxia, Neurosci. Lett. 273 (1999), 13-16.
21. J.N. Halle, C.E. Kasper, J.M. Gidday and B.J. Koos, Enhancing adenosine A1 receptor binding reduces hypoxic-ischemic brain injury in newborn rats, Brain Res. 759 (1997), 309-312.
22. N. Hershkowitz, A.N. Katchman and S. Veregge, Site of synaptic depression during hypoxia: a patch-clamp analysis, J. Neurophysiol. 69 (1993), 432-441.
23. S. Hess, C.E. Müller, W. Frobenius, U. Reith, K.N. Klotz and K. Eger, 7-Deazaadenines bearing polar substituents: structure-activity relationships of new A(1) and A(3) adenosine receptor antagonists, J. Med. Chem. 43(24) (2000), 4636-4646.
24. K.S. Hsu and C.C. Huang, Characterization of the anoxia-induced long-term synaptic potentiation in area CA1 of the rat hippocampus, Br. J. Pharmacol. 122 (1997), 671-681.
25. KA. Jacobson, P.J.M. van Galen and M. Williams, Adenosine receptors: pharmacology, structure-activity relationships and therapeutic potential, J. Med. Chem. 35 (1992), 407-422.
26. K.A. Jacobson, K.S. Park, J.L. Jiang, Y.C. Kim, M.E. Olah, G.L. Stiles and X.D. Ji, Pharmacological characterization of novel A3 adenosine receptor- selective antagonists, Neuropharmacology 36 (1997), 1157-1165.
27. K.A. Jacobson, Adenosine A3 receptors: novel ligands and paradoxical effects, Trends Pharmacol. Sci. 19 (1998), 184-191.
28. B. Johansson, L. Halldner T.V. Dunwiddie, S.A. Masino, W. Poelchen, L. Gimenez-Llort, R.M. Escorihuela, A. Fernandez-Teruel, Z. Wiesenfeld-Hallin, X.J. Xu, A. Hardemark, C. Betsholtz, E. Herlenius and B.B. Fredholm, Hyperalgesia, anxiety, and decreased hypoxic neuroprotecnon in mice lacking the adenosine A1 receptor, Proc. Natl. Acad. Sci. USA, 98 (2001), 9407-9412.
29. H.O. Kim, X.D. Ji, N. Melman, M.E. Olah, G.L. Stiles and K.A. Jacobson, Selective ligands for rat adenosine receptors: structure-activity relationships of 1,3-dialkylxanthine 7-riboside derivatives, J. Med. Chem. 37 (1994), 4020-4030.
30. S. Latini, F. Bordoni, F. Pedata and R. Corradetti, Extracellular adenosine concentrations during in vitro ischaemia in rat hippocampal slices, Br. J. Pharmacol. 127 (1999), 729-739.
31. J. Leblond and K. Krnjevic, Hypoxic changes in hippocampal neurons, J. Neurophysiol. 62(1) (1989) 1-14.
32. A.H. Li, S. Moro, N. Melman, X.D. Ji and KA. Jacobson, Structure-activity relationships and molecular modeling of 3,5-diacyl-2,4-dialkylpyridine derivatives as selective A3 adenosine receptor antagonists, J. Med. Chem. 41 (1998), 3186-3201.
33. J. Linden, J.A. Auchampach, X. Jin and R.A. Figler, The structure and function of A1 and A2B adenosine receptors, Life Sci. 62 (1998), 1519-1524.
34. A. Monopoli, G. Lozza, A. Forlani, A. Mattavelli and E. Ongini, Blockade of adenosine A2A receptors by SCH 58261 results in neuroprotective effects in cerebral ischaemia in rats, Neuroreport 9(17) (1998), 3955-3959.
35. C.E. Müller and T. Scior, Adenosine receptors and their modulators, Pharm. Acta Helv. 68 (1993), 77-111.
36. K. Nieber, J. Sevcik and P. Illes, Hypoxic changes in rat locus coeruleus neurons in vitro, J. Physiol. 486(Pt 1) (1995), 33-46.
37. K. Nieber, W. Poelchen, D. Sieler and P. Illes, Inhibition by ethanol of excitatory amino acid receptors in rat locus coeruleus neurons in vitro, Naunyn-Schmiedeberg's Arch. Pharmacol. 357 (1998), 299-308.
38. E. Oberdisse and E.G. Lapetina, GDP beta S enhances the activation of phospholipase C caused by thrombin in human platelets: evidence for involvement of an inhibitory GTP-binding protein, Biochem. Biophys. Res. Commun. 144(3) (1987), 1188-1196.
39. T.M. Palmer and G.L. Stiles, Adenosine receptors, Neuropharmacology 34 (1995), 683-694.
40. Z.P. Pang, P. Deng, Y.W. Ruan and Z.C. Xu, Depression of fast excitatory synaptic transmission in large aspiny neurons of the neostriatum after transient forebrain ischemia, J. Neurosci. 22(24) (2002), 10948-10957.
41. F.E. Parkinson, C.J. Sinclair, T. Othman, N.J. Haughey and J.D. Geiger, Differences between rat primary cortical neurons and astrocytes in purine release evoked by ischemic conditions, Neuropharmacology 43 (2002), 836-846.
42. M.A. Perez-Pinzon, P.L. Mumford, M. Rosenthal and T.J. Sick, Anoxic preconditioning in hippocampal slices: role of adenosine, Neuroscience 75 (1996), 687-694.
43. P. Popoli, A. Pintor, M.R. Domenici, C. Frank, M.T Tebano, A. Pezzola, L. Scarchilli, D. Quarta, R. Reggio, F. Malchiodi-Albedi, M. Falchi and M. Massotti, Blockade of striatal adenosine A2A receptor reduces, through a presynaptic mechanism, quinolinic acid-induced excitotoxicity: possible relevance to neuroprotective interventions in neurodegenerative diseases of the striatum, J. Neurosci. 22(5) (2002), 1967-1975.
44. K.A. Rudolphi, P. Schubert, F.E. Parkinson and B.B. Fredholm, Neuroprotective role of adenosine in cerebral ischaemia, Trends Pharmacol. Sci. 13 (1992), 439-445.
45. G.L. Stiles, Adenosine receptors, J. Biol. Chem. 267 (1992), 6451-6454.
46. A.L. Tucker and J. Linden, Cloned receptors and cardiovasular responses to adenosine, Cardiovasc. Res. 27 (1993), 62-67.
47. P.J.M. van Galen, G.L. Stiles, G. Michaels and K.A. Jacobson, Adenosine A1 and A3 receptors: structure activity relationships, Med. Chem. Review 12 (1992), 423-471.
48. D.K. von Lubitz, R.C. Lin, P. Popik, M.F. Carter and K.A. Jacobson, Adenosine A3 receptor stimulation and cerebral ischemia, Eur. J. Pharmacol. 263 (1994), 59-67.
49. D.K. von Lubitz, R.C. Lin and K.A. Jacobson, Cerebral ischemia in gerbils: effects of acute and chronic treatment with adenosine A2A receptor agonist and antagonist, Eur. J. Pharmacol. 287(3) (1995), 295-302.
50. D.K. von Lubitz, R.C. Lin, N. Bischofberger, M. Beenhakker, M. Boyd, R. Lipartowska and K.A. Jacobson, Protection against ischemic damage by adenosine amine congener, a potent and selective adenosine A1 receptor agonist, Eur. J. Pharmacol. 369 (1999), 313-317.
51. L.G. Wu and P. Saggau, Adenosine inhibits evoked synaptic transmission primarily by reducing presynaptic calcium influx in area CA1 of hippocampus, Neuron 12(5) (1994), 1139-1148.
52. P.J. Zhu and K. Krnjevic, Anoxia selectively depresses excitatory synaptic transmission in hippocampal slices, Neurosci. Lett. 166 (1994), 27-30.